"The decision results from the changing environment of COVID-19 with the rapid deployment of vaccin…

Inovio said its trial is on hold until it answers questions from the Food and Drug Administration, …

Inovio said its COVID-19 vaccine will begin phase 2/3 clinical trials in the US in September, not o…

Inovio's Tuesday morning release of early-stage data on its COVID-19 vaccine candidate sent shares …

The Phase 1 study will enroll up to 40 healthy adult volunteers in Philadelphia and Kansas Cit…

Each volunteer will receive two doses of the vaccine four weeks apart. Inovio expects quick enrollm…

Vaccines often require difficult testing in thousands of people before being allowed on market. For…

Shares of Inovio Pharmaceuticals, Moderna Inc., and Novavax Inc. all surged Monday as China's coron…

Investors have increased short bets on healthcare stocks as the industry faces potentially more scr…

Typically, the US Food and Drug Administration requires an additional study to confirm a vaccine wo…

Economic data out of China further lifted investor sentiments. Industrial profits in the country ga…

Drugmakers and health officials have been hoping to significantly cut down those timelines in respo…

House Speaker Nancy Pelosi said on Sunday that Democrats' new $2.4 trillion stimulus proposal could…

Gilead Pharmaceuticals already sells a drug, remdesivir, that a World Health Organization official …

Both approaches are based on decades of research but have yet to lead to any vaccines approved by t…

One way: Use a harmless virus to carry the spike protein into the body. It's easier to produce but …

These are Business Insider's biggest healthcare stories for September 29.

US stocks closed higher as strong economic data outweighed investors' fears of the capital gains ta…

US senator Rick Scott claimed "communist China won't share" its coronavirus vaccine. China's minist…

The World Health Organization this week counted more than five dozen other vaccine candidates in e…